Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

NCT00246857 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT00246857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00246857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Observational
Overall status
Recruiting
Start date
February 12, 2007
Completion date
Not reported
Enrollment
5,000 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

primary immune deficiency